DR Horton Offers Value, Momentum, And Growth

DR Horton looks very attractively valued on a revenue, earnings, and book value relative basis.The stock outperformed in 2014 after a strong second half of the year. The stock also boasts solid EPS growth and return on equity numbers. We rate DHI as a 'BUY', and expect to see outperformance in 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.